AMEX:BDR

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Blonder Tongue Laboratories

Executive Summary

Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States.


Snowflake Analysis

Adequate balance sheet and overvalued.


Similar Companies

Share Price & News

How has Blonder Tongue Laboratories's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BDR's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

5.8%

BDR

0.3%

US Communications

1.2%

US Market


1 Year Return

-12.0%

BDR

-5.8%

US Communications

16.8%

US Market

Return vs Industry: BDR underperformed the US Communications industry which returned -4.4% over the past year.

Return vs Market: BDR underperformed the US Market which returned 16.4% over the past year.


Shareholder returns

BDRIndustryMarket
7 Day5.8%0.3%1.2%
30 Day8.0%4.4%4.9%
90 Day52.2%14.4%20.0%
1 Year-12.0%-12.0%-3.3%-5.8%19.3%16.8%
3 Year55.8%55.8%43.4%33.7%43.7%34.4%
5 Year40.0%40.0%65.6%47.4%75.5%56.6%

Price Volatility Vs. Market

How volatile is Blonder Tongue Laboratories's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Blonder Tongue Laboratories undervalued compared to its fair value and its price relative to the market?

1.46x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate BDR's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate BDR's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: BDR is unprofitable, so we can't compare its PE Ratio to the US Communications industry average.

PE vs Market: BDR is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BDR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BDR is good value based on its PB Ratio (1.5x) compared to the US Communications industry average (2x).


Next Steps

Future Growth

How is Blonder Tongue Laboratories forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.9%

Forecasted Tech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Blonder Tongue Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Blonder Tongue Laboratories performed over the past 5 years?

33.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BDR is currently unprofitable.

Growing Profit Margin: BDR is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: BDR is unprofitable, but has reduced losses over the past 5 years at a rate of 33.8% per year.

Accelerating Growth: Unable to compare BDR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BDR is unprofitable, making it difficult to compare its past year earnings growth to the Communications industry (-29.6%).


Return on Equity

High ROE: BDR has a negative Return on Equity (-150.84%), as it is currently unprofitable.


Next Steps

Financial Health

How is Blonder Tongue Laboratories's financial position?


Financial Position Analysis

Short Term Liabilities: BDR's short term assets ($10.7M) exceed its short term liabilities ($8.8M).

Long Term Liabilities: BDR's short term assets ($10.7M) exceed its long term liabilities ($2.4M).


Debt to Equity History and Analysis

Debt Level: BDR's debt to equity ratio (56.8%) is considered high.

Reducing Debt: BDR's debt to equity ratio has increased from 44.9% to 56.8% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BDR has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: BDR is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.


Next Steps

Dividend

What is Blonder Tongue Laboratories's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate BDR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate BDR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if BDR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BDR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BDR's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.6yrs

Average management tenure


CEO

Ted Grauch (54 yo)

0.58

Tenure

US$323,983

Compensation

Mr. Edward Rowland Grauch, also known as Ted, has been the Chief Executive Officer at Blonder Tongue Laboratories, Inc. since January 1, 2020. Mr. Grauch has been the President of Blonder Tongue Laboratori ...


CEO Compensation Analysis

Compensation vs Market: Ted's total compensation ($USD323.98K) is below average for companies of similar size in the US market ($USD593.60K).

Compensation vs Earnings: Ted's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Edward Grauch
President & CEO0.58yrUS$323.98k1.96%
$ 155.2k
Eric Skolnik
Senior VP19.25yrsUS$278.84k0.089%
$ 7.0k
Allen Horvath
Senior Vice President of Operations0.58yrUS$249.50k0.59%
$ 47.0k
Ronald Alterio
Senior VP of Engineering & CTO2.08yrsUS$285.78k0.14%
$ 10.8k
Robert Pallé
MD of Strategic Accounts & Director26.92yrsUS$534.32k28.04%
$ 2.2m

0.6yrs

Average Tenure

55yo

Average Age

Experienced Management: BDR's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Robert Pallé
MD of Strategic Accounts & Director26.92yrsUS$534.32k28.04%
$ 2.2m
Anthony Bruno
Independent Director12.5yrsUS$59.54k2.29%
$ 181.4k
Gary Scharmett
Independent Director22.67yrsUS$50.67k2.92%
$ 230.6k
James Williams
Independent Director26.92yrsUS$55.54k2.36%
$ 186.3k
James Williams
Independent Director5.5yrsUS$50.54k4.44%
$ 351.0k
Stephen Necessary
Independent Director2.58yrsUS$59.64k0.69%
$ 54.4k
Steven Shea
Independent Chairman5.25yrsUS$90.14k6.63%
$ 524.1k
Charles Dietz
Independent Director8.92yrsUS$63.28k2.43%
$ 192.4k
John Burke
Independent Director0.58yrno datano data
Michael Hawkey
Independent Director0.17yrno datano data

7.2yrs

Average Tenure

63.5yo

Average Age

Experienced Board: BDR's board of directors are considered experienced (7.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Blonder Tongue Laboratories, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Blonder Tongue Laboratories, Inc.
  • Ticker: BDR
  • Exchange: AMEX
  • Founded: 1950
  • Industry: Communications Equipment
  • Sector: Tech
  • Market Cap: US$7.909m
  • Shares outstanding: 9.77m
  • Website: https://www.blondertongue.com

Number of Employees


Location

  • Blonder Tongue Laboratories, Inc.
  • One Jake Brown Road
  • Old Bridge
  • New Jersey
  • 8857
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BDRAMEX (NYSE MKT LLC)YesCommon StockUSUSDDec 1995

Biography

Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the Unite ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/08/10 23:50
End of Day Share Price2020/08/10 00:00
Earnings2020/03/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.